A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury - What it showed and taught?

Brain Injury

Volumn 23, Issue 6, 2009, Pages 548-558

  Tenovuo, Olli ^a   Alin, Jouni ^a   Helenius, Hans ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Crossover study; Placebo controlled trial; Randomized controlled trial; Rivastigmine; Traumatic brain injury

Indexed keywords

APOLIPOPROTEIN E; CHOLINERGIC RECEPTOR STIMULATING AGENT; PLACEBO; RIVASTIGMINE;

ADULT; ALCOHOLISM; ANOREXIA; APPETITE; ARTICLE; BACKACHE; BALANCE DISORDER; BLADDER DYSFUNCTION; BODY TEMPERATURE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COLD; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIARRHEA; DISEASE DURATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; EYE PAIN; FATIGUE; FEAR; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HAIR GROWTH; HEART PALPITATION; HUMAN; HYPERACTIVITY; HYPERSEXUALITY; HYPERTENSION; HYPOTENSION; INSOMNIA; INTERVIEW; INVOLUNTARY MOVEMENT; IRRITABILITY; LIBIDO; LIMB PAIN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MYOCLONUS; NAUSEA; NERVOUSNESS; NEUROPSYCHOLOGICAL TEST; NIGHTMARE; OUTCOME ASSESSMENT; PARESTHESIA; PATIENT COMPLIANCE; PSYCHOSIS; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RESTLESS LEGS SYNDROME; RESTLESSNESS; SIDE EFFECT; SOCIAL JUSTICE; SPASTICITY; STOMACH PAIN; SWEATING; SYNCOPE; THORAX PAIN; TIME; TINNITUS; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; TREMOR; VISUAL DISORDER; VISUAL HALLUCINATION; VOMITING; XEROSTOMIA;

EID: 67650571799     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.1080/02699050902926275     Document Type: Article

References (41)

1. Thurman, D., Alverson, C., Dunn, K., Guerrero, J. and Sniezek, J. (1999) Traumatic brain injury in the United States: A public health perspective. Journal of Head Trauma Rehabilitation, 14, pp. 602-615.
2. Mazaux, J-M, Masson, F., Levin, HS, Alaoui, P., Maurette, P. and Barat, M. (1997) Long-term neuropsychological outcome and loss of social autonomy after traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 78, pp. 1316-1320.
3. Graham, DI, Adams, JH, Nicoll, JA, Maxwell, WL and Gennarelli, TA (1995) The nature, distribution and causes of traumatic brain injury. Brain Pathology, 5, pp. 397-406.
4. Salmond, CH, Chatfield, DA, Menon, DK, Pickard, JD and Sahakian, BJ (2005) Cognitive sequelae of head injury: Involvement of basal forebrain and associated structures. Brain, 128, pp. 189-200.
5. Bentley, P., Vuilleumier, P., Thiel, CM, Driver, J. and Dolan, RJ (2003) Cholinergic enhancement modulates neural correlates of selective attention and emotional processing. Neuroimage, 20, pp. 58-70.
6. Dekker, AJAM, Connor, DJ and Thal, LJ (1991) The role of cholinergic projections from the nucleus basalis in memory. Neuroscience and Biobehavior Review, 15, pp. 299-317.
7. Semba, K. (2000) Multiple output pathways of the basal forebrain: Organization, chemical heterogeneity, and roles in vigilance. Behavioral Brain Research, 115, pp. 117-141.
8. Gorman, LK, Fu, K., Hovda, DA, Murray, M. and Traystman, RJ (1996) Effects of traumatic brain injury on the cholinergic system in the rat. Journal of Neurotrauma, 13, pp. 457-463.
9. Schmidt, RH and Grady, MS (1995) Loss of forebrain cholinergic neurons following fluid percussion injury: Implications for cognitive impairment in closed head injury. Journal of Neurosurgery, 83, pp. 496-502.
10. Dewar, D. and Graham, DI (1996) Depletion of choline acetyltransferase activity but preservation of M1 and M2 muscarinic receptor binding sites in temporal cortex following head injury-a preliminary human post-mortem study. Journal of Neurotrauma, 13, pp. 181-187.
11. Murdoch, I., Perry, EK, Court, JA, Graham, DI and Dewar, D. (1998) Cortical cholinergic dysfunction after human head injury. Journal of Neurotrauma, 15, pp. 295-305.
12. Leigh Verbois, S, Scheff, SW and Pauly, JR (2002) Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury. Journal of Neurotrauma, 19, pp. 1569-1585.
13. Levin, HS, Peters, BH, Kalisky, Z., High, WM, von Laufen, A., Eisenberg, HM, Morrison, DP and Gary Jr, HE (1986) Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Central Nervous System Trauma, 3, pp. 333-342.
14. Cardenas, DD, McLean Jr, A., Farrell-Roberts, L., Baker, L., Brooke, M. and Haselkom, J. (1994) Oral physostigmine and impaired memory in adults with brain injury. Brain Injury, 8, pp. 579-587.
15. Masanic, CA, Bayley, MT, van Reekum, R. and Simard, M. (2001) Open-label study of donepezil in traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 82, pp. 896-901.
16. Whelan, FJ, Walker, MS and Schultz, SK (2000) Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury. Annals of Clinical Psychiatry, 12, pp. 131-135.
17. Whitlock Jr, JA (1999) Brain injury, cognitive impairment, and donepezil. Journal of Head Trauma Rehabilitation, 14, pp. 424-427.
18. Bourgeois, JA, Bahadur, N. and Minjares, S. (2002) Donepezil for cognitive deficits following traumatic brain injury: A case report. Journal of Neuropsychiatry and Clinical Neuroscience, 14, pp. 463-464.
19. Kaye, NS, Townsend 3rd, JB and Ivins, R. (2003) An open-label trial of donepezil (Aricept) in the treatment of persons with mild traumatic brain injury. Journal of Neuropsychiatry and Clinical Neuroscience, 15, pp. 383-385.
20. Zhang, L., Plotkin, RC, Wang, G., Sandel, ME and Lee, S. (2004) Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Archives of Physical Medicine and Rehabilitation, 85, pp. 1050-1055.
21. Silver, JM, Koumaras, B., Chen, M., Mirski, D., Potkin, SG, Reyes, P., Warden, D., Harvey, PD, Arciniegas, D., Katz, DI and Gunay, I. (2006) Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology, 67, pp. 748-755.
22. Pike, BR and Hamm, RJ (1997) Activating the posttraumatic cholinergic system for the treatment of cognitive impairment following traumatic brain injury. Pharmacology and Biochemical Behavior, 57, pp. 785-791.
23. Arciniegas, D., Adler, L., Topkoff, J., Cawthra, E., Filley, CM and Reite, M. (1999) Attention and memory dysfunction after traumatic brain injury: Cholinergic mechanisms, sensory gating, and a hypothesis for further investigation. Brain Injury, 13, pp. 1-13.
24. Griffin, SL, van Reekum, R. and Masanic, C. (2003) A review of cholinergic agents in the treatment of neurobehavioral deficits following traumatic brain injury. Journal of Neuropsychiatry and Clinical Neuroscience, 15, pp. 17-26.
25. Arciniegas, DB (2003) The cholinergic hypothesis of cognitive impairment caused by traumatic brain injury. Current Psychiatry Reports, 5, pp. 391-399.
26. Tenovuo, O. (2006) Cholinergic treatment of traumatic brain injury. Current Drug Therapy, 1, pp. 187-209.
27. Poole, NA and Agrawal, N. (2008) Cholinomimetic agents and neurocognitive impairment following head injury: A systematic review. Brain Injury, 22, pp. 519-534.
28. Tenovuo, O. (2005) Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 29, pp. 65-69.
29. American Congress of Rehabilitation Medicine (1993) Definition of mild traumatic brain injury. Journal of Head Trauma Rehabilitation, 8, pp. 86-87.
30. Derogatis, LR, Lipman, RS and Covi, L. (1973) SCL-90: An outpatient psychiatric rating scale-preliminary report. Psychopharmacology Bulletin, 9, pp. 13-28.
31. Diener, E., Emmons, RA, Larsen, RJ and Griffin, S. (1985) The satisfaction with life scale. Journal of Personality Assessment, 49, pp. 71-75.
32. Revonsuo, A. and Portin, R. (1995) CogniSpeed© The computer based measurement of cognitive processing., University of Turku., AboaTech Ltd, Turku, Finland
33. Jennett, B., Snoek, J., Bond, MR and Brooks, N. (1981) Disability after severe head injury: Observations on the use of the Glasgow Outcome Scale. Journal of Neurology, Neurosurgery and Psychiatry, 44, pp. 285-293.
34. King, NS, Crawford, S., Wenden, FJ, Moss, NE, Wade, DT and Caldwell, FE (1997) Measurement of post-traumatic amnesia: How reliable is it? Journal of Neurology, Neurosurgery and Psychiatry, 62, pp. 38-42.
35. Donohoe, GG, Salomaki, A., Lehtimaki, T., Pulkki, K. and Kairisto, V. (1999) Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel electrophoresis. Clinical Chemistry, 45, pp. 143-146.
36. Grizzle, JE (1965) The two-period change-over design and its use in clinical trials. Biometrics, 21, pp. 469-480.
37. Jones, B. and Kenward, MG (2003) Design and analysis of cross-over trials, Chapman & Hall/CRC, Boca Raton, FL
38. Teasdale, GM, Nicoll, JAR, Murray, G. and Fiddes, M. (1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet, 350, pp. 1069-1071.
39. Ariza, M., Pueyo, R., Matarin, M del M, Junque, C., Mataro, M., Clemente, I., Moral, P., Poca, MA, Garnacho, A. and Sahuquillo, J. (2006) Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. Journal of Neurology, Neurosurgery and Psychiatry, 77, pp. 1191-1193.
40. Dikmen, SS, Machamer, J., Temkin, N. and McLean, A. (1990) Neuropsychological recovery in patients with moderate to severe head injury: 2 year follow-up. Journal of Clinical and Experimental Neuropsychology, 12, pp. 507-519.
41. Silver, JM, Yudofsky, SC and Hales, RE (1994) Neuropsychiatry of traumatic brain injury., American Psychiatric Press, Washington, DC